Cargando…

Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population

BACKGROUND: The pathological changes in Alzheimer's Disease (AD) and other neurodegenerative disorders begin decades prior to their clinical expression. However, the clinical diagnosis of neurodegenerative dementias is not straightforward. Lactoferrin is an iron-binding, antimicrobial glycoprot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gleerup, Helena Sophia, Jensen, Camilla Steen, Høgh, Peter, Hasselbalch, Steen Gregers, Simonsen, Anja Hviid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122152/ https://www.ncbi.nlm.nih.gov/pubmed/33975253 http://dx.doi.org/10.1016/j.ebiom.2021.103361

Ejemplares similares

Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review
por: Gleerup, Helena Sophia, et al.
Publicado: (2019)

Progression of Blood-Brain Barrier Leakage in Patients with Alzheimer’s Disease as Measured with the Cerebrospinal Fluid/Plasma Albumin Ratio Over Time
por: Musaeus, Christian Sandøe, et al.
Publicado: (2023)

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease
por: Jensen, Camilla Steen, et al.
Publicado: (2017)

The Added Value of Cerebrospinal Fluid Neurofilament Light Chain to Existing Diagnostic Methods and Biomarkers in a Mixed Memory Clinic Cohort of Consecutive Patients
por: Gleerup, Helena Sophia, et al.
Publicado: (2022)

Comparison of the clinical impact of 2-[(18)F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer’s disease
por: Gjerum, Le, et al.
Publicado: (2021)

Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives
por: Jensen, Camilla Steen, et al.
Publicado: (2015)

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting
por: Schjønning Nielsen, Malene, et al.
Publicado: (2016)

Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer’s disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2023)

Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise
por: Jensen, Camilla Steen, et al.
Publicado: (2019)

Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
por: Rostgaard, Nina, et al.
Publicado: (2023)

Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer’s disease
por: Delgado-Peraza, Francheska, et al.
Publicado: (2023)

Cerebrospinal fluid osmolality cannot predict development or surgical outcome of idiopathic normal pressure hydrocephalus
por: Oernbo, Eva Kjer, et al.
Publicado: (2022)

Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer’s Disease
por: Jensen, Camilla Steen, et al.
Publicado: (2020)

Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study
por: Schjønning Nielsen, Malene, et al.
Publicado: (2018)

Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study
por: Knorr, Ulla, et al.
Publicado: (2019)

Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus
por: Lolansen, Sara Diana, et al.
Publicado: (2021)

Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer’s disease and mild cognitive impairment
por: Poulsen, Keld, et al.
Publicado: (2014)

A 16-Week Aerobic Exercise Intervention Does Not Affect Hippocampal Volume and Cortical Thickness in Mild to Moderate Alzheimer’s Disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2018)

Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort
por: Gramkow, Mathias Holsey, et al.
Publicado: (2020)

Evaluating 2-[(18)F]FDG-PET in differential diagnosis of dementia using a data-driven decision model
por: Gjerum, Le, et al.
Publicado: (2020)

Cost-effectiveness of a randomised trial of physical activity in Alzheimer’s disease: a secondary analysis exploring patient and proxy-reported health-related quality of life measures in Denmark
por: Sopina, Elizaveta, et al.
Publicado: (2017)

Inflammatory Markers in Cerebrospinal Fluid from Patients with Hydrocephalus: A Systematic Literature Review
por: Lolansen, Sara Diana, et al.
Publicado: (2021)

Resting State EEG in Exercise Intervention Studies: A Systematic Review of Effects and Methods
por: Gramkow, Mathias Holsey, et al.
Publicado: (2020)

Effects of aerobic exercise on event-related potentials related to cognitive performance: a systematic review
por: Gusatovic, Julia, et al.
Publicado: (2022)

Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure
por: Oernbo, Eva K., et al.
Publicado: (2022)

Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?
por: Boschi, Silvia, et al.
Publicado: (2022)

Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer’s Disease
por: Sobol, Nanna A., et al.
Publicado: (2018)

Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer’s disease biomarkers
por: van Zalm, Patrick W., et al.
Publicado: (2023)

Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort
por: Muurling, Marijn, et al.
Publicado: (2020)

Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer's disease
por: Frederiksen, Kristian S., et al.
Publicado: (2019)

Origin of MMP-8 and Lactoferrin levels from gingival crevicular fluid, salivary glands and whole saliva
por: Ramenzoni, Liza L., et al.
Publicado: (2021)

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
por: Leuzy, Antoine, et al.
Publicado: (2016)

Subjective social status is an important determinant of perceived stress among adolescents: a cross-sectional study
por: Steen, Pernille Bach, et al.
Publicado: (2020)

A zero-dose synthetic baseline for the personalized analysis of [(18)F]FDG-PET: Application in Alzheimer’s disease
por: Hinge, Christian, et al.
Publicado: (2022)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Cerebrospinal fluid in Alzheimer's: A precious tool
por: Parnetti, Lucilla, et al.
Publicado: (2016)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m8kd9rhdumrg1nvmn33ah9bavn